{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:07:00Z","timestamp":1762448820790,"version":"build-2065373602"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"DOI":"10.1186\/s12950-025-00476-4","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:52:09Z","timestamp":1762444329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity"],"prefix":"10.1186","volume":"22","author":[{"given":"Fran\u00e7ois","family":"Santinon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan-Helen Henderson","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelyn J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrinda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Wirasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khashayar","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Bartish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson. H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Victoria","family":"del Rincon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"1","key":"476_CR1","doi-asserted-by":"publisher","first-page":"2360196","DOI":"10.1080\/19491034.2024.2360196","volume":"15","author":"JC Mars","year":"2024","unstructured":"Mars JC, Culjkovic-Kraljacic B, Borden KLB. eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production. Nucleus. 2024;15(1):2360196.","journal-title":"Nucleus"},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"109689","DOI":"10.1016\/j.cellsig.2020.109689","volume":"73","author":"X Yang","year":"2020","unstructured":"Yang X, Zhong W, Cao R. Phosphorylation of the mRNA cap-binding protein eIF4E and cancer. Cell Signal. 2020;73:109689.","journal-title":"Cell Signal"},{"issue":"48","key":"476_CR3","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","volume":"25","author":"Y Mamane","year":"2006","unstructured":"Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N. mTOR, translation initiation and cancer. Oncogene. 2006;25(48):6416\u201322.","journal-title":"Oncogene"},{"issue":"15","key":"476_CR4","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","volume":"24","author":"T Ueda","year":"2004","unstructured":"Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol. 2004;24(15):6539\u201349.","journal-title":"Mol Cell Biol"},{"issue":"21","key":"476_CR5","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1128\/MCB.00448-10","volume":"30","author":"M Shveygert","year":"2010","unstructured":"Shveygert M, Kaiser C, Bradrick SS, Gromeier M. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol Cell Biol. 2010;30(21):5160\u20137.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"476_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/bjc.2015.450","volume":"114","author":"JH Carter","year":"2016","unstructured":"Carter JH, Deddens JA, Spaulding NI, Lucas D, Colligan BM, Lewis TG, et al. Phosphorylation of eIF4E Serine 209 is associated with tumour progression and reduced survival in malignant melanoma. Br J Cancer. 2016;114(4):444\u201353.","journal-title":"Br J Cancer"},{"issue":"15","key":"476_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4161\/cbt.8.15.8960","volume":"8","author":"S Fan","year":"2009","unstructured":"Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, Sun SY. Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues. Cancer Biol Ther. 2009;8(15):1463\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"476_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1158\/1078-0432.CCR-09-0986","volume":"16","author":"A Yoshizawa","year":"2010","unstructured":"Yoshizawa A, Fukuoka J, Shimizu S, Shilo K, Franks TJ, Hewitt SM, et al. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res. 2010;16(1):240\u20138.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"476_CR9","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1101\/gad.1604407","volume":"21","author":"HG Wendel","year":"2007","unstructured":"Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232\u20137.","journal-title":"Genes Dev"},{"issue":"16","key":"476_CR10","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/onc.2014.146","volume":"34","author":"N Robichaud","year":"2015","unstructured":"Robichaud N, del Rincon SV, Huor B, Alain T, Petruccelli LA, Hearnden J, et al. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene. 2015;34(16):2032\u201342.","journal-title":"Oncogene"},{"issue":"32","key":"476_CR11","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1073\/pnas.1005320107","volume":"107","author":"L Furic","year":"2010","unstructured":"Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A. 2010;107(32):14134\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"476_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41591-018-0321-2","volume":"25","author":"Y Xu","year":"2019","unstructured":"Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, et al. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat Med. 2019;25(2):301\u201311.","journal-title":"Nat Med"},{"key":"476_CR13","doi-asserted-by":"crossref","unstructured":"Huang F, Gon\u00e7alves C, Bartish M, R\u00e9my-Sarrazin J, Issa ME, Cordeiro B, et al. Inhibiting the MNK1\/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses. J Clin Invest. 2021;131(8).","DOI":"10.1172\/JCI140752"},{"issue":"14","key":"476_CR14","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1158\/0008-5472.CAN-20-3143","volume":"81","author":"Q Guo","year":"2021","unstructured":"Guo Q, Bartish M, Goncalves C, Huang F, Smith-Voudouris J, Krisna SS, et al. The MNK1\/2-eIF4E axis supports immune suppression and metastasis in postpartum breast cancer. Cancer Res. 2021;81(14):3876\u201389.","journal-title":"Cancer Res"},{"issue":"5","key":"476_CR15","first-page":"579","volume":"4","author":"S Tan","year":"2022","unstructured":"Tan S, Day D, Nicholls SJ, Segelov E. Immune checkpoint inhibitor therapy in oncology: current uses and future directions: JACC: cardiooncology State-of-the-Art review. JACC: CardioOncology. 2022;4(5):579\u201397.","journal-title":"JACC: CardioOncology"},{"issue":"5","key":"476_CR16","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam A, Prasad V. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open. 2019;2(5):e192535\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"476_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Reviews Clin Oncol. 2019;16(9):563\u201380.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"476_CR18","doi-asserted-by":"publisher","first-page":"e2352302","DOI":"10.1001\/jamanetworkopen.2023.52302","volume":"7","author":"S Cook","year":"2024","unstructured":"Cook S, Samuel V, Meyers DE, Stukalin I, Litt I, Sangha R, et al. Immune-Related adverse events and survival among patients with metastatic NSCLC treated with immune checkpoint inhibitors. JAMA Netw Open. 2024;7(1):e2352302\u2013e.","journal-title":"JAMA Netw Open"},{"key":"476_CR19","doi-asserted-by":"publisher","first-page":"800879","DOI":"10.3389\/fimmu.2021.800879","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, Wang J, Lin N, Zhou Y, He W, Liu J, et al. Immune checkpoint Inhibitor-Associated colitis: from mechanism to management. Front Immunol. 2021;12:800879.","journal-title":"Front Immunol"},{"issue":"2","key":"476_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.14309\/ajg.0000000000000497","volume":"115","author":"E Bellaguarda","year":"2020","unstructured":"Bellaguarda E, Hanauer S. Checkpoint Inhibitor-Induced colitis. Am J Gastroenterol. 2020;115(2):202\u201310.","journal-title":"Am J Gastroenterol"},{"key":"476_CR21","doi-asserted-by":"crossref","unstructured":"Gougis P, Jochum F, Abbar B, Dumas E, Bihan K, Lebrun-Vignes B, et al. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade\u2014a worldwide perspective. eClinicalMedicine. 2024;70.","DOI":"10.1016\/j.eclinm.2024.102536"},{"issue":"10","key":"476_CR22","first-page":"680","volume":"32","author":"M Zoghbi","year":"2024","unstructured":"Zoghbi M, Burk KJ, Haroun E, Saade M, Carreras MTC. Immune checkpoint inhibitor-induced diarrhea and colitis: an overview. Support Care Cancer. 2024;32(10):680.","journal-title":"Support Care Cancer"},{"issue":"8","key":"476_CR23","doi-asserted-by":"publisher","first-page":"e00746","DOI":"10.14309\/ctg.0000000000000746","volume":"15","author":"S Varma","year":"2024","unstructured":"Varma S, Sullivan K, DiCarlo J, Coromilas A, Staller K, Dougan M. The development of persistent Gastrointestinal symptoms in patients with melanoma who have had an immune checkpoint Inhibitor-Related Gastrointestinal toxicity. Clin Transl Gastroenterol. 2024;15(8):e00746.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"476_CR24","first-page":"20210027","volume":"3","author":"G Cappello","year":"2021","unstructured":"Cappello G, Molea F, Campanella D, Galioto F, Russo F, Regge D. Gastrointestinal adverse events of immunotherapy. BJR Open. 2021;3(1):20210027.","journal-title":"BJR Open"},{"key":"476_CR25","unstructured":"Tomivosertib (eFT-508) in combination with PD-1\/PD-L1 inhibitor therapy: a study of subjects administered anti-PD-1\/anti-PD-L1 therapy that are experiencing insufficient response to checkpoint inhibitor alone [Internet]. Study registered on 2018\/07\/25 and completed on 2021-06-30. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03616834"},{"issue":"3","key":"476_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1158\/1078-0432.CCR-24-0841","volume":"31","author":"C Ferrario","year":"2025","unstructured":"Ferrario C, Mackey J, Gelmon KA, Levasseur N, Sorensen PH, Oo HZ, et al. Phase Ib pharmacodynamic study of the MNK inhibitor Tomivosertib (eFT508) combined with Paclitaxel in patients with refractory metastatic breast cancer. Clin Cancer Res. 2025;31(3):491\u2013502.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"476_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.4049\/jimmunol.1200026","volume":"190","author":"BK Gorentla","year":"2013","unstructured":"Gorentla BK, Krishna S, Shin J, Inoue M, Shinohara ML, Grayson JM, et al. Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2013;190(3):1026\u201337.","journal-title":"J Immunol"},{"issue":"2","key":"476_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3748\/wjg.v12.i2.302","volume":"12","author":"TW Kim","year":"2006","unstructured":"Kim TW, Seo JN, Suh YH, Park HJ, Kim JH, Kim JY, et al. Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J Gastroenterol. 2006;12(2):302\u20135.","journal-title":"World J Gastroenterol"},{"key":"476_CR29","doi-asserted-by":"crossref","unstructured":"Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:15.25.1-15.25.14.","DOI":"10.1002\/0471142735.im1525s104"},{"issue":"9","key":"476_CR30","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20130573","volume":"210","author":"Y Bulliard","year":"2013","unstructured":"Bulliard Y, Jolicoeur R, Windman M, Rue SM, Ettenberg S, Knee DA, et al. Activating Fc \u03b3 receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J Exp Med. 2013;210(9):1685\u201393.","journal-title":"J Exp Med"},{"issue":"9","key":"476_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1084\/jem.20130579","volume":"210","author":"TR Simpson","year":"2013","unstructured":"Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med. 2013;210(9):1695\u2013710.","journal-title":"J Exp Med"},{"issue":"10","key":"476_CR32","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","volume":"28","author":"L Khoja","year":"2017","unstructured":"Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review. Ann Oncol. 2017;28(10):2377\u201385.","journal-title":"Ann Oncol"},{"issue":"1","key":"476_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-024-01199-4","volume":"14","author":"MJ Abraham","year":"2024","unstructured":"Abraham MJ, Goncalves C, McCallum P, Gupta V, Preston SEJ, Huang F, et al. Tunable phenocycler imaging of the murine pre-clinical tumour microenvironments. Cell Bioscience. 2024;14(1):19.","journal-title":"Cell Bioscience"},{"issue":"1","key":"476_CR34","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"3","key":"476_CR35","doi-asserted-by":"publisher","first-page":"107523","DOI":"10.1016\/j.celrep.2020.107523","volume":"31","author":"CR Stoltzfus","year":"2020","unstructured":"Stoltzfus CR, Filipek J, Gern BH, Olin BE, Leal JM, Wu Y, et al. CytoMAP: A Spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues. Cell Rep. 2020;31(3):107523.","journal-title":"Cell Rep"},{"issue":"44","key":"476_CR36","doi-asserted-by":"publisher","first-page":"27556","DOI":"10.1073\/pnas.1920377117","volume":"117","author":"M Bartish","year":"2020","unstructured":"Bartish M, Tong D, Pan Y, Wallerius M, Liu H, Ristau J, et al. MNK2 governs the macrophage antiinflammatory phenotype. Proc Natl Acad Sci U S A. 2020;117(44):27556\u201365.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"476_CR37","doi-asserted-by":"publisher","first-page":"E2202","DOI":"10.1073\/pnas.1717439115","volume":"115","author":"N Robichaud","year":"2018","unstructured":"Robichaud N, Hsu BE, Istomine R, Alvarez F, Blagih J, Ma EH, et al. Translational control in the tumor microenvironment promotes lung metastasis: phosphorylation of eIF4E in neutrophils. Proc Natl Acad Sci U S A. 2018;115(10):E2202\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"476_CR38","doi-asserted-by":"crossref","unstructured":"Pham TN, Spaulding C, Shields MA, Metropulos AE, Shah DN, Khalafalla MG, et al. Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8\u2009+\u2009T cell antitumor immunity. JCI Insight. 2022;7(9).","DOI":"10.1172\/jci.insight.152731"},{"issue":"8","key":"476_CR39","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ni.3205","volume":"16","author":"X Su","year":"2015","unstructured":"Su X, Yu Y, Zhong Y, Giannopoulou EG, Hu X, Liu H, et al. Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation. Nat Immunol. 2015;16(8):838\u201349.","journal-title":"Nat Immunol"},{"issue":"5609","key":"476_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057\u201361.","journal-title":"Science"},{"issue":"4","key":"476_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/art.41134","volume":"72","author":"F Santinon","year":"2020","unstructured":"Santinon F, Batignes M, Mebrek ML, Biton J, Clavel G, Herve R, et al. Involvement of tumor necrosis factor receptor type II in FoxP3 stability and as a marker of Treg cells specifically expanded by Anti-Tumor necrosis factor treatments in rheumatoid arthritis. Arthritis Rheumatol. 2020;72(4):576\u201387.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"476_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2014.07.030","volume":"158","author":"X Li","year":"2014","unstructured":"Li X, Liang Y, LeBlanc M, Benner C, Zheng Y. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell. 2014;158(4):734\u201348.","journal-title":"Cell"},{"issue":"7","key":"476_CR43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/2326-6066.CIR-20-0969","volume":"9","author":"M Grigoriou","year":"2021","unstructured":"Grigoriou M, Banos A, Hatzioannou A, Kloetgen A, Kouzis P, Aggouraki D, et al. Regulatory T-cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors. Cancer Immunol Res. 2021;9(7):726\u201334.","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"476_CR44","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.celrep.2019.01.066","volume":"26","author":"Y Luo","year":"2019","unstructured":"Luo Y, Xue Y, Wang J, Dang J, Fang Q, Huang G, et al. Negligible effect of sodium chloride on the development and function of TGF-beta-Induced CD4(+) Foxp3(+) regulatory T cells. Cell Rep. 2019;26(7):1869\u201379. e3.","journal-title":"Cell Rep"},{"issue":"1","key":"476_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1600-6143.2003.00293.x","volume":"4","author":"S Fu","year":"2004","unstructured":"Fu S, Yopp AC, Mao X, Chen D, Zhang N, Chen D, et al. CD4\u2009+\u2009CD25\u2009+\u2009CD62\u2009+\u2009T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transpl. 2004;4(1):65\u201378.","journal-title":"Am J Transpl"},{"issue":"4","key":"476_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1189\/jlb.1A0715-296R","volume":"99","author":"MT Huang","year":"2016","unstructured":"Huang MT, Lin BR, Liu WL, Lu CW, Chiang BL. Lymph node trafficking of regulatory T cells is prerequisite for immune suppression. J Leukoc Biol. 2016;99(4):561\u20138.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"476_CR47","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","volume":"105","author":"J Ermann","year":"2005","unstructured":"Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, et al. Only the CD62L\u2009+\u2009subpopulation of CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells protects from lethal acute GVHD. Blood. 2005;105(5):2220\u20136.","journal-title":"Blood"},{"issue":"11","key":"476_CR48","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1136\/gutjnl-2018-316948","volume":"67","author":"E Soularue","year":"2018","unstructured":"Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, et al. Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut. 2018;67(11):2056\u201367.","journal-title":"Gut"},{"issue":"6","key":"476_CR49","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/eji.200838292","volume":"38","author":"A Mor","year":"2008","unstructured":"Mor A, Keren G, Kloog Y, George J. N-Ras or K-Ras Inhibition increases the number and enhances the function of Foxp3 regulatory T cells. Eur J Immunol. 2008;38(6):1493\u2013502.","journal-title":"Eur J Immunol"},{"key":"476_CR50","doi-asserted-by":"crossref","unstructured":"Ju M, Zhang J, Deng Z, Wei M, Ma L, Chen T, et al. Prophylactic IL-23 Blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. J Immunother Cancer. 2024;12(7).","DOI":"10.1136\/jitc-2024-009345"},{"issue":"7756","key":"476_CR51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","volume":"569","author":"E Perez-Ruiz","year":"2019","unstructured":"Perez-Ruiz E, Minute L, Otano I, Alvarez M, Ochoa MC, Belsue V, et al. Prophylactic TNF Blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Nature. 2019;569(7756):428\u201332.","journal-title":"Nature"},{"issue":"1","key":"476_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12915-020-00765-9","volume":"18","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liang W, Luo L, Sun S, Wang F. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biol. 2020;18(1):29.","journal-title":"BMC Biol"},{"issue":"2","key":"476_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ccell.2025.01.004","volume":"43","author":"LM Braun","year":"2025","unstructured":"Braun LM, Giesler S, Andrieux G, Riemer R, Talvard-Balland N, Duquesne S, et al. Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity. Cancer Cell. 2025;43(2):269\u2013. \u2013\u200991.e19.","journal-title":"Cancer Cell"},{"issue":"8","key":"476_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/OP.20.00002","volume":"16","author":"Z Gong","year":"2020","unstructured":"Gong Z, Wang Y. Immune checkpoint Inhibitor-Mediated diarrhea and colitis: A clinical review. JCO Oncol Pract. 2020;16(8):453\u201361.","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"476_CR55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/apt.13281","volume":"42","author":"A Gupta","year":"2015","unstructured":"Gupta A, De Felice KM, Loftus EV Jr., Khanna S. Systematic review: colitis associated with anti-CTLA-4 therapy. Aliment Pharmacol Ther. 2015;42(4):406\u201317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"476_CR56","doi-asserted-by":"publisher","first-page":"e1524695","DOI":"10.1080\/2162402X.2018.1524695","volume":"8","author":"DY Wang","year":"2019","unstructured":"Wang DY, Mooradian MJ, Kim D, Shah NJ, Fenton SE, Conry RM, et al. Clinical characterization of colitis arising from anti-PD-1 based therapy. Oncoimmunology. 2019;8(1):e1524695.","journal-title":"Oncoimmunology"},{"issue":"7","key":"476_CR57","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H. Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci. 2019;110(7):2080\u20139.","journal-title":"Cancer Sci"},{"issue":"20","key":"476_CR58","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, et al. PD-1(+) regulatory T cells amplified by PD-1 Blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A. 2019;116(20):9999\u201310008.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"476_CR59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.25429","volume":"127","author":"H Nishikawa","year":"2010","unstructured":"Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127(4):759\u201367.","journal-title":"Int J Cancer"},{"key":"476_CR60","doi-asserted-by":"publisher","first-page":"104378","DOI":"10.1016\/j.cellimm.2021.104378","volume":"365","author":"X Chen","year":"2021","unstructured":"Chen X, Li S, Long D, Shan J, Li Y. Rapamycin facilitates differentiation of regulatory T cells via enhancement of oxidative phosphorylation. Cell Immunol. 2021;365:104378.","journal-title":"Cell Immunol"},{"issue":"1","key":"476_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","volume":"111","author":"R Zeiser","year":"2008","unstructured":"Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, et al. Differential impact of mammalian target of Rapamycin Inhibition on CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells compared with conventional CD4\u2009+\u2009T cells. Blood. 2008;111(1):453\u201362.","journal-title":"Blood"},{"issue":"16","key":"476_CR62","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","volume":"65","author":"SY Sun","year":"2005","unstructured":"Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, et al. Activation of Akt and eIF4E survival pathways by Rapamycin-mediated mammalian target of Rapamycin Inhibition. Cancer Res. 2005;65(16):7052\u20138.","journal-title":"Cancer Res"},{"key":"476_CR63","doi-asserted-by":"crossref","unstructured":"Nguyen TU, Hector H, Pederson EN, Lin J, Ouyang Z, Wendel HG, et al. Rapamycin-Induced feedback activation of eIF4E-EIF4A dependent mRNA translation in pancreatic cancer. Cancers (Basel). 2023;15(5).","DOI":"10.3390\/cancers15051444"},{"issue":"16","key":"476_CR64","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.febslet.2013.06.045","volume":"587","author":"RL Stead","year":"2013","unstructured":"Stead RL, Proud CG. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a). FEBS Lett. 2013;587(16):2623\u20138.","journal-title":"FEBS Lett"},{"issue":"21","key":"476_CR65","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1128\/MCB.00760-07","volume":"27","author":"X Wang","year":"2007","unstructured":"Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, et al. Inhibition of mammalian target of Rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation. Mol Cell Biol. 2007;27(21):7405\u201313.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"476_CR66","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1021\/mp300699d","volume":"10","author":"S Li","year":"2013","unstructured":"Li S, Jia Y, Jacobson B, McCauley J, Kratzke R, Bitterman PB, et al. Treatment of breast and lung cancer cells with a N-7 benzyl Guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. Mol Pharm. 2013;10(2):523\u201331.","journal-title":"Mol Pharm"},{"issue":"5","key":"476_CR67","doi-asserted-by":"publisher","first-page":"e1003494","DOI":"10.1371\/journal.pgen.1003494","volume":"9","author":"E Bjur","year":"2013","unstructured":"Bjur E, Larsson O, Yurchenko E, Zheng L, Gandin V, Topisirovic I, et al. Distinct translational control in CD4\u2009+\u2009T cell subsets. PLoS Genet. 2013;9(5):e1003494.","journal-title":"PLoS Genet"},{"issue":"5","key":"476_CR68","doi-asserted-by":"publisher","first-page":"106683","DOI":"10.1016\/j.isci.2023.106683","volume":"26","author":"R Istomine","year":"2023","unstructured":"Istomine R, Al-Aubodah TA, Alvarez F, Smith JA, Wagner C, Piccirillo CA. The eIF4EBP-eIF4E axis regulates CD4(+) T cell differentiation through modulation of T cell activation and metabolism. iScience. 2023;26(5):106683.","journal-title":"iScience"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-025-00476-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:02:42Z","timestamp":1762448562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal-inflammation.biomedcentral.com\/articles\/10.1186\/s12950-025-00476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s12950-025-00476-4","relation":{},"ISSN":["1476-9255"],"issn-type":[{"type":"electronic","value":"1476-9255"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments described were conducted in compliance with the Canadian Council of Animal Care guidelines and regulations. Animal protocols were reviewed and approved by McGill University Animal Care and Use Committee (JGH-8168). Blood samples were obtained from healthy controls at Jewish General Hospital (JGH). Informed consent was obtained from all participants in accordance with IRB-approved protocol (MP-05-2019-2017 approved by Research Ethics Board of the CIUSSS West Central Montreal).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}